MCP – a new option for treating chronic heart failure

Cardiola’s therapeutic approach, based on an innovative application of a proven operating principle, advances the long-since validated therapeutic mechanism of counter pulsation. This therapeutic mechanism could previously only be used in the clinical ICU setting or required elaborate technical equipment.

Cardiola’s patented method now enables the non-invasive, home-based application of this operating principle for the first time.

MCP has been technically perfected and medically certified. Its CE certification reflects its full compliance with the European standards as well as the requirements of Swissmedic, the Swiss Agency for Therapeutic Products.